May 7, 2025

Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis

Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr. Falk Pharma, a research-based pharmaceutical […]

Namibian Athletes Secure Spots at Tokyo Deaflympics

Windhoek: Several athletes have qualified to represent Namibia at the Deaflympics scheduled for Tokyo, Japan, from 15 to 26 November 2025. The qualifying events took place at the National Youth Service (NYS) Centre in Rietfontein, Otjozondjupa Region,…

NWR’s NamLeisure Benefits Now Include Camping Discounts

Windhoek: Namibia Wildlife Resorts (NWR) has announced that from 07 May 2025, all NamLeisure card holders will now enjoy discounted rates on camping across all its resorts and campsites. This new benefit forms part of NWR’s ongoing efforts to make loc…